top of page
AdobeStock_215067298.jpeg

Exciting things are happening here...

Keep up to date with the latest developments from Alera Bio, our team, and partners.

Be sure to check back often for the latest news from our laboratory and around the industry.

Announcements / Press Releases

Alera Bio expands and strengthens IP portfolio with exclusive license 

April 9, 2026

Alera Bio enters into exclusive licensing agreement with BLA Technology, LLC for expanded thyroid hormone portfolio

Alera Bio appoints Andy Eisen, MD, PhD as Chief Scientific Officer

April 8, 2026

Alera Bio proud to announce the appointment of Chief Scientific Officer to lead all research and development

Alera Bio Launches Newly Re-Designed Website

November 14, 2025

Alera Bio launches newly designed website to include HCP, Patient, and investor resources

Alera Bio Announces Appointment of Board of Directors

November 11, 2025

Alera Bio proud to announce the appointment of the board of directors who will guide Alera Bio

Alera Bio Announces Appointment of Executive Leadership Team

September 26, 2025

Alera Bio proud to announce the appointment of executive team who will lead Alera Bio

Alera Bio Launches to Advance Breakthrough Therapies for Rare Neurological Disorders

July 3, 2025

Alera Bio, Inc. forms as a Delaware C Corporation to Revolutionizing Life-Changing Therapies for Neurological Conditions 

Announcements

Alera Bio Launches Lead Rare Disease Program for MCT-8 Deficiency Therapy

September 18, 2025

Alera Bio enters into exclusive licensing agreement with BLA Technology, LLC for MCT-8 Deficiency Program 
bottom of page